GERN

Geron Corporation - Common Stock (GERN)

About Geron Corporation - Common Stock (GERN)

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.

Details

Daily high

$1.31

Daily low

$1.28

Price at open

$1.30

52 Week High

$2.01

52 Week Low

$1.04

Market cap

835.2M

Dividend yield

Volume

5.9M

Avg. volume

11.4M

P/E ratio

-12.43

Geron Corporation - Common Stock News